[Change in aggregation and 5-hydroxytryptamine content of thrombocytes exposed to serotonin antagonists].
D000470:Alkaloids / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology; D000636:Aminosalicylic Acids / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D004123:Dimethylamines / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D007211:Indoles / Q000494:pharmacology; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists
D000470:Alkaloids; D000636:Aminosalicylic Acids; D004123:Dimethylamines; D007211:Indoles; D012702:Serotonin Antagonists; D000628:Aminophylline; D012701:Serotonin; D010208:Papaverine; D004878:Ergotamine
Izmenenie agregatsii i soderzhanie 5-oksitriptamina v trombotsitakh pod vliianiem antagonistov serotonina.